Evans CP - Search Results

1

Autophagy as a modulator and target in prostate cancer.

Farrow JM, Yang JC, Evans CP. Farrow JM, et al. Among authors: evans cp. Nat Rev Urol. 2014 Sep;11(9):508-16. doi: 10.1038/nrurol.2014.196. Epub 2014 Aug 19. Nat Rev Urol. 2014. PMID: 25134829 Free PMC article. Review.

2

Testicular cancer metastatic exclusively to the brain and spleen.

Nguyen MM, Corr AS, Evans CP. Nguyen MM, et al. Among authors: evans cp. Urology. 2004 Jan;63(1):176-8. doi: 10.1016/j.urology.2003.08.021. Urology. 2004. PMID: 14751386

3

Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.

Lee LF, Louie MC, Desai SJ, Yang J, Chen HW, Evans CP, Kung HJ. Lee LF, et al. Among authors: evans cp. Oncogene. 2004 Mar 18;23(12):2197-205. doi: 10.1038/sj.onc.1207344. Oncogene. 2004. PMID: 14767470

4

Medical and surgical palliative care of patients with urological malignancies.

Ok JH, Meyers FJ, Evans CP. Ok JH, et al. Among authors: evans cp. J Urol. 2005 Oct;174(4 Pt 1):1177-82. doi: 10.1097/01.ju.0000173077.84274.01. J Urol. 2005. PMID: 16145365 Review.

5

Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivation.

Nelson EC, Cambio AJ, Yang JC, Lara PN Jr, Evans CP. Nelson EC, et al. Among authors: evans cp. Nat Clin Pract Urol. 2007 Feb;4(2):82-94. doi: 10.1038/ncpuro0700. Nat Clin Pract Urol. 2007. PMID: 17287869 Review.

6

Nonreceptor tyrosine kinases in prostate cancer.

Chang YM, Kung HJ, Evans CP. Chang YM, et al. Among authors: evans cp. Neoplasia. 2007 Feb;9(2):90-100. doi: 10.1593/neo.06694. Neoplasia. 2007. PMID: 17357254 Free PMC article. Review.

7

Economic analysis of active surveillance for localized prostate cancer.

Kim S 2nd, Dall'Era MA, Evans CP. Kim S 2nd, et al. Among authors: evans cp. Curr Opin Urol. 2012 May;22(3):247-53. doi: 10.1097/MOU.0b013e328351dd32. Curr Opin Urol. 2012. PMID: 22388666 Review.

8

CRM1 blockade by selective inhibitors of nuclear export attenuates kidney cancer growth.

Inoue H, Kauffman M, Shacham S, Landesman Y, Yang J, Evans CP, Weiss RH. Inoue H, et al. Among authors: evans cp. J Urol. 2013 Jun;189(6):2317-26. doi: 10.1016/j.juro.2012.10.018. Epub 2012 Oct 16. J Urol. 2013. PMID: 23079374 Free PMC article.

9

NF-κB2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants.

Nadiminty N, Tummala R, Liu C, Yang J, Lou W, Evans CP, Gao AC. Nadiminty N, et al. Among authors: evans cp. Mol Cancer Ther. 2013 Aug;12(8):1629-37. doi: 10.1158/1535-7163.MCT-13-0027. Epub 2013 May 22. Mol Cancer Ther. 2013. PMID: 23699654 Free PMC article.

10

Lin28 promotes growth of prostate cancer cells and activates the androgen receptor.

Tummala R, Nadiminty N, Lou W, Zhu Y, Gandour-Edwards R, Chen HW, Evans CP, Gao AC. Tummala R, et al. Among authors: evans cp. Am J Pathol. 2013 Jul;183(1):288-95. doi: 10.1016/j.ajpath.2013.03.011. Am J Pathol. 2013. PMID: 23790802 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters